Sirius NeoSight
Lyon
About Sirius NeoSight
Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.6M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: sirius-neosight.com
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/sirius-neosight-97120 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.